Reverse mergers are all the rage as cash-depleted public biotechs search for viable next chapters, with Korro Bio and Frequency Therapeutics the latest to fuse.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,